Dose reductions in thalidomide-naive and thalidomide-exposed patients
| . | No prior exposure to thalidomide . | Prior exposure to thalidomide . | ||
|---|---|---|---|---|
| . | Len/Dex, n = 226 . | Placebo/Dex, n = 204 . | Len/Dex, n = 127 . | Placebo/Dex, n = 147 . |
| Median dose, mg/d | ||||
| Lenalidomide or placebo | 25 | 25 | 25 | 25 |
| Dexamethasone | 40 | 40 | 40 | 40 |
| Patients with 1 or more dose reduction, no. (%) | ||||
| Lenalidomide or placebo | 80 (35.4) | 27 (13.2) | 49 (38.6) | 11 (7.5) |
| Dexamethasone | 66 (29.2) | 31 (15.2) | 35 (27.6) | 23 (15.8) |
| . | No prior exposure to thalidomide . | Prior exposure to thalidomide . | ||
|---|---|---|---|---|
| . | Len/Dex, n = 226 . | Placebo/Dex, n = 204 . | Len/Dex, n = 127 . | Placebo/Dex, n = 147 . |
| Median dose, mg/d | ||||
| Lenalidomide or placebo | 25 | 25 | 25 | 25 |
| Dexamethasone | 40 | 40 | 40 | 40 |
| Patients with 1 or more dose reduction, no. (%) | ||||
| Lenalidomide or placebo | 80 (35.4) | 27 (13.2) | 49 (38.6) | 11 (7.5) |
| Dexamethasone | 66 (29.2) | 31 (15.2) | 35 (27.6) | 23 (15.8) |
Dex indicates dexamethasone; and Len, lenalidomide.